IS8081A - Meðferð á ástandi þar sem amýlóíðskellur koma viðsögu - Google Patents

Meðferð á ástandi þar sem amýlóíðskellur koma viðsögu

Info

Publication number
IS8081A
IS8081A IS8081A IS8081A IS8081A IS 8081 A IS8081 A IS 8081A IS 8081 A IS8081 A IS 8081A IS 8081 A IS8081 A IS 8081A IS 8081 A IS8081 A IS 8081A
Authority
IS
Iceland
Prior art keywords
repaired
treatment
condition
amyloid plaques
amyloid
Prior art date
Application number
IS8081A
Other languages
English (en)
Inventor
M. Strittmatter Stephen
H.S. Lee Daniel
Li Weiwei
Original Assignee
Yale University
Biogen Idec Ma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yale University, Biogen Idec Ma Inc filed Critical Yale University
Publication of IS8081A publication Critical patent/IS8081A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1787—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IS8081A 2003-04-16 2005-10-21 Meðferð á ástandi þar sem amýlóíðskellur koma viðsögu IS8081A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46342403P 2003-04-16 2003-04-16
PCT/US2004/011728 WO2004093893A2 (en) 2003-04-16 2004-04-16 Nogo-receptor antagonists for the treatment of conditions involving amyloid plaques

Publications (1)

Publication Number Publication Date
IS8081A true IS8081A (is) 2005-10-21

Family

ID=33310776

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8081A IS8081A (is) 2003-04-16 2005-10-21 Meðferð á ástandi þar sem amýlóíðskellur koma viðsögu

Country Status (15)

Country Link
US (1) US20070065429A1 (is)
EP (1) EP1615654A2 (is)
JP (1) JP2006523708A (is)
KR (1) KR20060023959A (is)
CN (1) CN1832752A (is)
AU (1) AU2004231742A1 (is)
BR (1) BRPI0409562A (is)
CA (1) CA2522649A1 (is)
EA (1) EA009643B1 (is)
IS (1) IS8081A (is)
MX (1) MXPA05011100A (is)
NO (1) NO20055392L (is)
RS (1) RS20050774A (is)
WO (1) WO2004093893A2 (is)
ZA (1) ZA200509242B (is)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7119165B2 (en) * 2000-01-12 2006-10-10 Yale University Nogo receptor-mediated blockade of axonal growth
DE60332842D1 (de) * 2002-08-10 2010-07-15 Univ Yale Antagonisten des nogo-rezeptors
EA008253B1 (ru) * 2003-08-07 2007-04-27 Байоджен Айдек Ма Инк. Антагонисты nogo-рецептора
BRPI0417959A (pt) * 2003-12-22 2007-03-27 Glaxo Group Ltd anticorpo ou fragmento funcional deste, composição farmcêutica, método para tratamento ou profilaxia de acidente vascular cerebral e outras doenças/distúrbios neurológicos em um ser humano, uso de um anticorpo anti-nogo, e, métodos para inibir a neurodegeneração e/ou promover a recuperação funcional em um paciente humano, para promover o crescimento axonal, para produzir um anticorpo anti-nogo e para produzir uma composição farmacêutica intravenosamente administrável
BRPI0507272A (pt) * 2004-01-30 2007-06-26 Biogen Idec Inc tratamento de condições que envolvem degeneração neuronal dopaminérgica, usando antagonistas do receptor nogo
US8581147B2 (en) 2005-03-24 2013-11-12 Lincoln Global, Inc. Three stage power source for electric ARC welding
US9956639B2 (en) 2005-02-07 2018-05-01 Lincoln Global, Inc Modular power source for electric ARC welding and output chopper
US8785816B2 (en) 2004-07-13 2014-07-22 Lincoln Global, Inc. Three stage power source for electric arc welding
US8269141B2 (en) 2004-07-13 2012-09-18 Lincoln Global, Inc. Power source for electric arc welding
US9855620B2 (en) 2005-02-07 2018-01-02 Lincoln Global, Inc. Welding system and method of welding
US9647555B2 (en) 2005-04-08 2017-05-09 Lincoln Global, Inc. Chopper output stage for arc welder power source
WO2007089601A2 (en) 2006-01-27 2007-08-09 Biogen Idec Ma Inc. Nogo receptor antagonists
JP2010502623A (ja) * 2006-08-31 2010-01-28 バイオジェン・アイデック・エムエイ・インコーポレイテッド Ｎｏｇｏレセプターポリペプチドの末梢投与に関する方法
EP2276500A4 (en) 2008-03-13 2015-03-04 Univ Yale REACTIVATION OF AXONE GROWTH AND CHRONIC MEDALLIONAL LESIONAL HEALING

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) * 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) * 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) * 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) * 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) * 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) * 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US5179017A (en) * 1980-02-25 1993-01-12 The Trustees Of Columbia University In The City Of New York Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4634665A (en) * 1980-02-25 1987-01-06 The Trustees Of Columbia University In The City Of New York Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4399216A (en) * 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4366241A (en) * 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4510245A (en) * 1982-11-18 1985-04-09 Chiron Corporation Adenovirus promoter system
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5168062A (en) * 1985-01-30 1992-12-01 University Of Iowa Research Foundation Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
US4968615A (en) * 1985-12-18 1990-11-06 Ciba-Geigy Corporation Deoxyribonucleic acid segment from a virus
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
GB9014932D0 (en) * 1990-07-05 1990-08-22 Celltech Ltd Recombinant dna product and method
WO1994004679A1 (en) * 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
JPH05244982A (ja) * 1991-12-06 1993-09-24 Sumitomo Chem Co Ltd 擬人化ｂ−ｂ１０
US6391311B1 (en) * 1998-03-17 2002-05-21 Genentech, Inc. Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1
US20020072493A1 (en) * 1998-05-19 2002-06-13 Yeda Research And Development Co. Ltd. Activated T cells, nervous system-specific antigens and their uses
JP2002518010A (ja) * 1998-06-16 2002-06-25 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ９４個のヒト分泌タンパク質
YU53502A (sh) * 2000-01-12 2005-11-28 Yale University Blokada aksonalnog rasta posredstvom nogo receptora
US7119165B2 (en) * 2000-01-12 2006-10-10 Yale University Nogo receptor-mediated blockade of axonal growth
US20030124704A1 (en) * 2000-10-06 2003-07-03 Strittmatter Stephen M. Nogo receptor homologs
WO2003018631A2 (en) * 2001-08-27 2003-03-06 Novartis Ag Nogo receptor homologues and their use
JP2005519584A (ja) * 2001-10-22 2005-07-07 ノバルティス アクチエンゲゼルシャフト Ｎｏｇｏレセプターホモログおよびそれらの使用
DE60332842D1 (de) * 2002-08-10 2010-07-15 Univ Yale Antagonisten des nogo-rezeptors
EA008253B1 (ru) * 2003-08-07 2007-04-27 Байоджен Айдек Ма Инк. Антагонисты nogo-рецептора

Also Published As

Publication number Publication date
WO2004093893A2 (en) 2004-11-04
MXPA05011100A (es) 2006-04-18
WO2004093893A3 (en) 2005-03-03
CN1832752A (zh) 2006-09-13
RS20050774A (en) 2007-12-31
ZA200509242B (en) 2006-12-27
CA2522649A1 (en) 2004-11-04
NO20055392L (no) 2005-11-15
EP1615654A2 (en) 2006-01-18
KR20060023959A (ko) 2006-03-15
EA009643B1 (ru) 2008-02-28
AU2004231742A1 (en) 2004-11-04
AU2004231742A2 (en) 2004-11-04
EA200501620A1 (ru) 2006-06-30
JP2006523708A (ja) 2006-10-19
US20070065429A1 (en) 2007-03-22
BRPI0409562A (pt) 2006-04-18

Similar Documents

Publication Publication Date Title
IS8081A (is) Meðferð á ástandi þar sem amýlóíðskellur koma viðsögu
DE602006020610D1 (de) Methacrylharz und herstellungsverfahren dafür
DE602007014040D1 (de) Kit zum reparieren und aufpumpen aufblasbarer artikel
DE602006010822D1 (de) Schleifartikel und herstellungsverfahren dafür
ZA200705297B (en) Methods and compositions for treating amyloid related diseases
NO20070251A (no) Brønnbehandling
NO20070297A (no) Brønnbehandling
ATE380780T1 (de) Wasserbehandlungskartuschenabsperrung
IL185396A0 (en) Methods of treating gastrointestinal inflammation
DE602005025091D1 (de) Piezooszillator und herstellungsverfahren dafür
IS8530A (is) Meðferð á truflunum í auga þar með talinni sjóndepilsrýrnun
CY2200156T2 (el) Επεξεργασια λυματων
DE602006009540D1 (de) L und herstellungsverfahren dafür
HK1105975A1 (en) Indoles useful in the treatment of inflammation
DE602006019201D1 (de) Rotor und herstellungsverfahren
IS8520A (is) Sambrædd pýrrólókarbasól og aðferðir við framleiðslu þeirra
DE602006020117D1 (de) Nadellager und herstellungsverfahren dafür
DE602004019377D1 (de) Reifenherstellungseinheit und Reifenherstellungsverfahren
DE602006019395D1 (de) Media-behandlungseinrichtung
IL187376A0 (en) Method of assessing the effectiveness of a treatment regimen
IS2372B (is) Tetrasólafleiður og aðferðir til að meðhöndla efnaskiptatengda sjúkdóma sem þeim tengjast
NO20053296L (no) Anordning og fremgangsmate for rengjoring av kompressor
DE602006010414D1 (de) Haarknüpfwerkzeug und herstellungsverfahren dafür
NO323496B1 (no) Fremgangsmate for rekondensering av avkoksgass
EP1805210A4 (en) NOVEL PEPTIDES AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASE